BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3620708)

  • 1. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
    Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
    Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia.
    Molica S; Alberti A
    Cancer; 1987 Dec; 60(11):2712-6. PubMed ID: 3677006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance.
    Montserrat E; Sanchez-Bisono J; Viñolas N; Rozman C
    Br J Haematol; 1986 Mar; 62(3):567-75. PubMed ID: 3954968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.
    Montserrat E; Viñolas N; Reverter JC; Rozman C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):359-61. PubMed ID: 3222145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow biopsy in chronic lymphocytic leukemia: a review of its prognostic importance.
    Montserrat E; Rozman C
    Blood Cells; 1987; 12(2):315-26. PubMed ID: 3304470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
    Melo JV; Catovsky D; Galton DA
    Blood Cells; 1987; 12(2):339-53. PubMed ID: 3476167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical staging and course of chronic lymphatic leukemia].
    Graf C; Graf-Würmli M; Streuli R; Rhyner K
    Schweiz Med Wochenschr; 1982 Nov; 112(46):1652-7. PubMed ID: 7156961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
    Dhodapkar M; Tefferi A; Su J; Phyliky RL
    Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of prognostic factors in chronic lymphocytic leukemia.
    Prokocimer M; Modan M; Lusky A; Hershko C
    Isr J Med Sci; 1985 Jun; 21(6):490-8. PubMed ID: 4019142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new parameter for chronic lymphocytic leukemia : determination of the large lymphocytes by means of Hemalog D (author's transl)].
    Vaugier G; Dighiero G; Charron D; Natali JC; Leporrier M; Debré P; d'Athis P; Binet JL
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):311-5. PubMed ID: 704345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in chronic lymphocytic leukemia.
    Chabronová I; Steruská M; Hrubisko M
    Czech Med; 1984; 7(4):201-9. PubMed ID: 6525933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological aspects of chronic lymphoid leukemia].
    Binet JL; Travade P; Chastang C; Dighiero G; Merle-Béral H; Raphael M
    C R Seances Soc Biol Fil; 1986; 180(5):503-11. PubMed ID: 2950973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S
    Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
    Rai KR; Han T
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokinetic studies in chronic lymphocytic leukemia. Relationship to other variables at diagnosis and survival.
    Petti MC; Testa MG; Deb G; Amadori S
    Biomedicine; 1980; 33(6):188-90. PubMed ID: 7213920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.